ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CSTM vs TMO // 10Y YIELD & FRED MACRO BETA

Constellium SE (France) (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: CSTM 4 — TMO 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CSTM VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CSTM TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 28.70% 9.30% +19.40 CSTM /roic <GO>
EV/EBITDA & P/E Valuation — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield 4.92% 2.40% +2.52 CSTM /fcf-yield <GO>
Operating Margin — 17.40% — TIE /operating-margins <GO>
Net Profit Margin 3.20% 15.10% -11.90 TMO /net-margins <GO>
Revenue Growth (YoY) 15.20% 3.90% +11.30 CSTM /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.50 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 8/9 -1.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.5 62.9 -19.40 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 9.9x 36.3x -26.40 CSTM /forward-pe <GO>
Enterprise Scale & Market Cap $3.23B $262.22B -$258.99B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CSTM REV TMO REV CSTM GROSS % TMO GROSS % CSTM FCF TMO FCF
FY 2025 $8.45B $44.56B — — $159.0M $6.29B
FY 2024 $7.33B $42.88B — — -$112.0M $7.27B
FY 2023 $7.83B $42.86B — — $432.0M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CSTM // BETA —
TMO // BETA 0.94